Spinal Muscular Atrophy (SMA) is an inherited neurodegenerative condition caused by reduction 6 in functional Survival Motor Neurones Protein (SMN). SMN has been implicated in transport of 7 mRNA in neural cells for local translation. We previously identified microtubule-dependant mobile 8 vesicles rich in SMN and the splicing factor SmB, a member of the Sm protein family, in neural 9 cells. By comparing the proteome of SmB to that of SmN, a neural-specific Sm protein, we now 10 show that the essential neural protein neurochondrin (NCDN) interacts with Sm proteins and SMN 11 in the context of mobile vesicles in neurites. NCDN has roles in protein localisation in neural cells, 12 and in maintenance of cell polarity. NCDN is required for the correct localisation of SMN, 13 suggesting they may both be required for formation and transport of trafficking vesicles. NCDN 14 provides a potential therapeutic target for SMA together with, or in place of, those targeting SMN 15 expression. 16 157 YFP-SmB and YFP-SmN were affinity purified using GFP-TRAP (Chromotek) from whole-cell lysates 158 of SH-SY5Y cell lines constitutively expressing the tagged proteins, with a cell line expressing YFP 159 alone as a control for non-specific binding to the tag or bead matrix. Immunoblot analysis using 160
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The inherited neurodegenerative disease, Spinal Muscular Atrophy (SMA) is caused by a 18 reduction in the amount of functional Survival Motor Neuron (SMN) protein (Lefebvre et al. 1995) . 19 SMA is the leading genetic cause of infant mortality, affecting 1:6000 live births (Monani 2005) . 20 The recently developed therapy, Spinraza/Nusinersin (Biogen) has been shown to increase the 21 level of SMN and improve the symptoms of SMA patients (Passini et al. 2011 , Finkel et al. 2016 , 22 Corey 2017). Most SMA patients harbour mutations in the SMN1 gene, which produces the 23 majority of total SMN protein in cells. In humans, expression from a variable number of copies of 24 an additional gene, SMN2, can produce some full-length SMN protein (Lefebvre et al. 1995 , 25 Lefebvre et al. 1997 ). The SMN2 gene, unlike SMN1, contains a point mutation in an exon splicing 26 enhancer , Lorson, Androphy 2000 resulting in truncation of most of the SMN 27 protein produced by SMN2 through skipping of exon 7. The truncated protein produced by SMN2 28 is less stable than full-length SMN and cannot compensate fully for the loss of SMN1 (Lorson et al. 29 1999, Lorson, Androphy 2000) . However, due to the small amounts of full length SMN expressed 30 from the SMN2 gene, the number of gene copies can influence the severity of SMA, with evidence 31 that five copies of SMN2 may be enough to compensate for loss of SMN1 (Campbell et al. 1997 , 32 Prior et al. 2004 ). It is not currently clear how a deficiency of functional SMN leads to the specific 33 symptoms of SMA. In particular, the differing sensitivity of cell types to lowered SMN levels, with 34 motor neurons most severely affected, is difficult to explain as SMN is an essential protein and 35 complete deletion is lethal at the cellular level (Schrank et al. 1997 , Hsieh-Li et al. 2000 . 36 37 SMN localises to nuclear bodies called gems (Gemini of Cajal bodies (CBs)) (Liu, Dreyfuss 38 1996) as well as in the cytoplasm where it has two well-established cellular roles (Monani 2005 , 39 Sleeman 2013, Li et al. 2014 , Tisdale, Pellizzoni 2015 . The first to be elucidated was a role in the 40 early stages of assembly and maturation of splicing snRNPs (small nuclear ribonucleoproteins). 41 Splicing snRNPs are ribonucleoprotein complexes, essential for pre-mRNA splicing, comprising an 42 snRNA (small nuclear RNA) core and numerous proteins including a heptameric ring containing 43 one copy each of members of the Sm protein family. SMN is part of a cytoplasmic complex, also 44 containing the gemin proteins, required for the addition the Sm proteins as a ring around the 45 snRNA core protein family have also been identified, beyond the core proteins usually found in splicing 91 snRNPs. Of particular interest in the context of SMA pathology is SmN (encoded by the SNRPN 92 gene), which is expressed in neural tissues (Schmauss et al. 1992 ) and can replace SmB in the 93 heptameric Sm protein ring (Huntriss et al. 1993 ). The human SmN protein differs from SmB' by 17 94 amino acids (UniProt Identifiers P63162 and P14678 respectively), and little is known about its 95 behaviour other than its incorporation into snRNPs, although the SNRPN gene locus is within the 96 paternally imprinted region of the genome critical in Prader-Willi Syndrome (Ozcelik et al. 1992) . 97 There is growing appreciation that some Sm proteins may 'moonlight' in functions beyond their 98 presence in splicing snRNPs. In addition to the role of SmB in cytoplasmic trafficking vesicles in 99 human cells, in Drosophila SmB and SmD3 are implicated in mRNA localisation (Gonsalvez et al. 100 2010) and SmD1 has a role in miRNA biogenesis (Xiong et al. 2015) . With this in mind, we applied a 101 proteomic approach in the neural cell line SH-SY5Y to search for interactions that could indicate 102 neural specific roles for the SmN protein of relevance for the pathology of SMA. 103 Our proteomic approach led to the identification of a novel interaction between SmN and 104 the essential protein Neurochondrin (NCDN). NCDN is predominantly expressed in neural tissue, 105 where it localises to dendrites, and is involved in the promotion of neural outgrowth (Shinozaki et within the cytoplasm, with some accumulation in CBs (Fig 1A, B ). This sequential localisation is 135 indistinguishable from that previously observed with YFP-SmB In HeLa and MCF-7 cells, though 136 CBs were not prominent in the majority of SH-SY5Y cells transiently expressing YFP-SmN. 137 Equivalent results were obtained in SH-SY5Y cells transiently expressing mCherry-SmN ( Fig S1) . 138 Both YFP-SmN and mCherry-SmN are efficiently incorporated into splicing snRNPs, as evidenced by 139 their enrichment from whole-cell lysates using antibodies against the characteristic 140 hypermethylated Cap structure (2,2,7-trimethylaguanosine) found on snRNAs ( Fig 1C) . 141 To determine whether the similarities between SmN and SmB extend to localisation in (movie S1). In common with the SmB vesicles, these stained positive with the lipophilic dye, 145 BODIPY 493, indicating that they are vesicular in nature ( Fig 1D) . Finally, to confirm that the (Fig 6A, B) . A reduction in the number of nuclear gems (identified 251 with SMN) was also observed, confirming that the shRNA was reducing SMN expression ( Fig 6A, C) . 252 This, together with data in Figure 5 To investigate whether the interaction between NCDN and SMN could reflect a previously 259 unidentified role for NCDN in snRNP assembly, splicing snRNPs were affinity purified from whole 260 cells lysates of SH-SY5Y cells constitutively expressing NCDN-GFP using agarose beads coupled to 261 antibodies against the characteristic tri-methyl guanosine Cap of snRNAs (TMG beads, Millipore) 262 ( Fig 7) . Endogenous Sm proteins showed strong enrichment in the affinity purified snRNP samples, 263 as expected for a core snRNP protein. Endogenous SMN was also co-enriched, demonstrating that 264 the experimental conditions were suitable to identify proteins important for snRNP assembly. 265 NCDN-GFP did not co-purify with splicing snRNPs, suggesting that NCDN is not involved in snRNP 266 assembly or processing. This raises the intriguing possibility that the interaction between SMN and 267 NCDN reflects a novel, snRNP-independent role for SMN. Fig 8A) . Furthermore, endogenous SMN also co-286 purified with mRFP-Rab5. In parallel experiments, co-localisation of mRFP-Rab5 with GFP-SMN and 287 NCDN was investigated (Fig 8B, C) . In accordance with previous publications, Rab5 showed partial 288 co-localisation with NCDN-GFP in cytoplasmic structures (arrows in Fig 8C) (Oku et al. 2013 ). GFP-289 SMN showed a similar degree of co-localisation with mRFP-Rab5, also in cytoplasmic structures, 290 while there was minimal co-localisation between YFP and mRFP-Rab5. Taken together with the 291 data in Figure 7 
Mass Spectrometry reveals the similarities between the interactomes of SmN and SmB
354
The SmN/SmB interactome screen presented here suggests a large number of non-snRNP proteins 355 as potential cellular partners for the Sm proteins. 356 We chose to investigate the neural protein NCDN further, as it has characteristics that may 357 be of relevance for SMA. NCDN is predominantly expressed in neural tissue, and little is known as a protein interacting with SmN but not SmB, further investigation indicates that NCDN is, in 369 fact, capable of interacting with both of these Sm proteins. Of much greater interest, however, is 370 the interaction documented between NCDN and SMN, which appears more robust than that 371 between NCDN and the Sm proteins ( Fig 3B, E) . Furthermore, NCDN is excluded from the cell 372 nucleus and localises with SMN and the Sm proteins in mobile vesicles in the neurites of SH-SY5Y 373 cells ( Fig 3D, F) suggesting that it shares cytoplasmic, rather than nuclear, roles with SMN. The Potential consequences of NCDN mis-localisation associated with SMN reduction 382 We have identified co-localisation of both SMN and NCDN with a sub-set of Rab5 vesicles. 383 Since NCDN is also found in a sub-set of SMN-positive cytoplasmic structures, it is highly likely that 384 these are Rab5 vesicles. It is possible that the protein-protein interactions between NCDN and 385 SMN occur elsewhere in the cytoplasm as both proteins also show a diffuse cytosolic pool, but the The gel chunks were cut into 1 mm cubes. These were then subjected to in-gel digestion, using a 513 ProGest Investigator in-gel digestion robot (Digilab) using standard protocols (Shevchenko et al. 514 1996) . Briefly, the gel cubes were destained by washing with MeCN and subjected to reduction 515 with DTT and alkylation with IAA before digestion overnight with trypsin at 37°C. The peptides 516 were extracted with 10% formic acid, and the volume reduced to ~20ul by concentration in a 517 speedvac (ThermoSavant). 518 The peptides were then injected onto an Acclaim PepMap 100 C18 trap and an Acclaim PepMap 519 RSLC C18 column (ThermoFisher Scientific), using a nanoLC Ultra 2D plus loading pump and 520 nanoLC as-2 autosampler (Eksigent). The peptides were eluted with a gradient of increasing 521 acetonitrile, containing 0.1 % formic acid (2-20% acetonitrile in 90 min, 20-40% in a further 30 min, 522 followed by 98% acetonitrile to clean the column, before re-equilibration to 2% acetonitrile). The (NCDN) was identified in the interactome of YFP-SmN, with 5 unique peptide hits encompassing 9% 976 sequence coverage. Each Ion score (Mascot Ion Score) was above the threshold for peptide identity (Mascot 977
Identity Score), with 2 out of the 5 identified peptides having a score of above double the threshold score. 978 979 
Figure 3: NCDN interacts with SmN, SmB and SMN, and co-localises with them in vesicles. A) Affinity
Figure 4: Detergent-free fractionation of SH-SY5Y cells reveals that SMN, coatomer proteins, NCDN, SmB
